Provided by Tiger Fintech (Singapore) Pte. Ltd.

Windtree Therapeutics, Inc.

0.5161
+0.066614.82%
Post-market: 0.51880.0042+0.82%19:59 EDT
Volume:2.55M
Turnover:1.24M
Market Cap:1.89M
PE:-0.01
High:0.5161
Open:0.4495
Low:0.4400
Close:0.4495
Loading ...

Windtree Files Istaroxime Cardiogenic Shock and Prevention of Arrythmias Patent for India

GlobeNewswire
·
27 Feb

Windtree Therapeutics Approves 1-for-50 Reverse Stock Split; Shares Fall Pre-Bell

MT Newswires Live
·
18 Feb

Windtree Therapeutics, Inc. Announces Reverse Stock Split

THOMSON REUTERS
·
18 Feb

Windtree Therapeutics Inc - Approves 1-for-50 Reverse Stock Split

THOMSON REUTERS
·
18 Feb

Windtree Therapeutics, Inc. Announces Reverse Stock Split

GlobeNewswire
·
18 Feb

Windtree announces issuance of patent in Japan for oncology pipeline

TIPRANKS
·
15 Jan

Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company’s Oncology Pipeline

GlobeNewswire
·
15 Jan

WINT and Ferguson announce strategic collaboration to elevate water management and leak mitigation for real estate and construction

PR Newswire
·
14 Jan

Windtree Therapeutics appoints Leanne Kelly to board of directors

TIPRANKS
·
13 Jan

Press Release: Windtree Announces the Addition of Leanne Kelly to Its Board of Directors

Dow Jones
·
13 Jan

Windtree Announces the Addition of Leanne Kelly to Its Board of Directors

THOMSON REUTERS
·
13 Jan

BRIEF-Windtree Therapeutics Announces New Corporate Strategy

Reuters
·
08 Jan

Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline

THOMSON REUTERS
·
08 Jan

Windtree Therapeutics Inc - to Acquire Strategic Subsidiaries With FDA-Approved Products

THOMSON REUTERS
·
08 Jan

Windtree Therapeutics Inc - to Use Equity for Acquisitions

THOMSON REUTERS
·
08 Jan

Press Release: Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline

Dow Jones
·
08 Jan